Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Rong Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4610-8618; OpenAlex author ID A5089001993. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. Correction: Pulsatilla Decoction and its bioactive component β-peltatin induce G2/M cell cycle arrest and apoptosis in pancreatic cancer. Co-author DOI 10.1186/s13020-025-01207-w↗
  2. Pulsatilla Decoction and its bioactive component β-peltatin induce G2/M cell cycle arrest and apoptosis in pancreatic cancer. Co-author DOI 10.1186/s13020-023-00774-0↗
  3. Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer. Co-author DOI 10.1007/s00261-015-0544-3↗
  4. Diagnosis of pancreatic cancer using ¹⁸F-FDG PET/CT and CA19-9 with SUVmax association to clinical characteristics. Last author PMID 26011335↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hong‐Xi Xu · 2 shared papers, 2023–2025 · strength 0.40
  2. Yunan Sun · 2 shared papers, 2015 · strength 0.12
  3. Siliang Wang · 1 shared paper, 2015 · strength 0.06
  4. Si-Liang Wang · 1 shared paper, 2015 · strength 0.05
  5. Xiaodong Chen · 1 shared paper, 2015 · strength 0.05
  6. Meiyue Tang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.